Monday 19 October 2026
Export PFSA’s income statement to Excel — free account
PROFUSA, Inc.
PFSA Healthcare Medical Devices
PROFUSA, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $100,000.00. In the quarter to June 2026, EPS grew 98.3%, free cash flow fell 359.3% and total debt fell 89.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.93
0.14
−13.08%
Follow PFSA
| Dec '17 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | 0.00 | — |
P/S ratio |
— | — | — | — | — | — | 0.00 | — |
Altman Z-Score |
— | — | — | — | — | — | (83.94) | — |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | (264.83) | — |
P/Operating CF |
— | — | — | — | — | — | (0.01) | — |
P/B ratio |
— | — | — | — | — | — | 0.00 | — |
Price to Tangible BV |
— | — | — | — | — | — | 0.00 | — |
EV/Sales |
— | — | — | — | — | — | 0.00 | — |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | — |
EV/Operating CF |
— | — | — | — | — | — | (22.80) | — |
EV/FCF |
— | — | — | — | — | — | (22.80) | — |
Quick Ratio |
— | 7.19 | 7.19 | 0.21 | 0.21 | 0.00 | 0.00 | 0.08 |
Current Ratio |
— | 10.32 | 10.32 | 0.55 | 0.55 | 0.32 | 0.00 | 0.17 |
Net Debt/EBITDA |
— | 16.43 | 16.47 | 0.15 | 0.15 | 0.00 | (10.47) | (0.42) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,539.11% | 356.79% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.40) | (0.51) |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Operating CF/Net income |
— | (2.21) | (2.21) | (0.08) | (0.08) | (1.78) | 0.22 | 0.45 |
Capex/Depreciation |
— | — | — | — | — | — | — | 0.00 |
Interest Coverage |
— | (13.88) | — | 0.00 | — | — | (1.02) | (5.44) |
| — | 0.00% | 0.33% | 0.00% | (219.58%) | (56.97%) | 15.05% | 49.12% | |
| — | 0.31% | 0.16% | 0.00% | 3.70% | 1.13% | (132.26%) | (1,046.23%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 30.28% | 30.28% | (1,690.10%) | (1,690.10%) | (34.73%) | 16.23% | 193.78% |
Average Days of Receivables |
— | 0.00 | 0.00 | — | — | — | 0.00 | — |
Research and Development Expense of Revenue |
— | — | — | — | — | — | 1,608.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | — | 0.00% | — | — | 2,992.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | — | — | — | 21.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | — | (34,733.28) | — |
Graham Number |
— | — | — | — | — | — | 563,367.81 | — |
Earnings Yield |
— | — | — | — | — | — | (303,159.67%) | — |
Free Cash Flow Yield |
— | — | — | — | — | — | (58,810.13%) | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 333.33 | 0.00 |
Operating CF per Share |
— | (0.03) | (1,104.00) | (0.02) | (830.29) | (2,949.86) | (6,886.67) | (4,778.82) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (590.59) |
Free Cash Flow per Share |
— | (0.03) | (1,104.00) | (0.02) | (830.29) | (2,949.86) | (6,886.67) | (5,369.41) |
Cash per Share |
— | 0.03 | 1,235.33 | 0.01 | 276.43 | 6.43 | 636.67 | 522.94 |
Shareholders Equity per Share |
— | 7.69 | (9,848.67) | 7.98 | (885.00) | (4,941.86) | (397,350.00) | (7,840.59) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 |
Book value per Share |
— | 7.69 | (9,848.67) | 7.98 | (885.00) | (4,941.86) | (397,350.00) | (7,840.59) |
Free Cash Flow |
— | (0.66) | (0.66) | (0.58) | (0.58) | (2.06) | (2.07) | (18.26) |
Working Capital |
— | 0.99 | 0.99 | (0.42) | (0.42) | (3.35) | (56.87) | (18.49) |
Capital Expenditures |
— | — | — | — | — | — | — | (2.01) |
Net Current Asset Value |
— | (6.22) | (197.87) | (1.32) | (194.84) | (12.77) | (122.02) | (26.67) |
EV/EBIT |
— | — | — | — | — | — | 0.00 | — |
Capex to Sales |
— | — | — | — | — | — | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | — | — | — | — | — | 0.00 |
Cash ROIC |
— | (0.36%) | 12.82% | (0.30%) | 136.43% | 59.77% | 2.88% | 159.99% |
Accounts Receivable Turnover |
— | — | 0.00 | — | — | — | 0.00 | — |
Accounts Payable Turnover |
— | — | — | — | — | — | 0.00 | 0.00 |
Average Days of Payables |
— | — | — | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 0.03 | — | — | — | — | — |
Average Payables |
— | — | — | — | — | — | 2.70 | 6.15 |
Average Assets |
— | 96.53 | 193.06 | 193.90 | 193.90 | 102.81 | 6.98 | 3.42 |
Average Common Equity |
— | — | 89.91 | 93.50 | (3.26) | (2.04) | (61.33) | (72.93) |
Columns are period end dates